Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay
- 1 February 1998
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 69 (2) , 195-200
- https://doi.org/10.1016/s0015-0282(97)00502-5
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormoneFertility and Sterility, 1998
- Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokineticsFertility and Sterility, 1994
- Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSHFertility and Sterility, 1994
- The two‐period cross‐over clinical trial.British Journal of Clinical Pharmacology, 1979
- EFFECTS OF HUMAN MENOPAUSAL GONADOTROPHIN PREPARATIONS IN DIFFERENT BIOASSAY METHODSActa Endocrinologica, 1964